ALMR - Company ID 0002104204
The table below shows Alamar Biosciences, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 |
|---|---|
| Cash & equivalents | $64.59M |
| Short-term investments | $0.00 |
| Receivables | $19.52M |
| Inventory | $39.93M |
| Total current assets | $141.47M |
| Property, plant & equipment | $10.47M |
| Goodwill | - |
| Total assets | $186.45M |
| Accounts payable | $5.63M |
| Total current liabilities | $24.05M |
| Long-term debt | - |
| Total liabilities | $129.53M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Retained earnings |
| -$190.10M |
| Total equity | -$178.07M |